It has been determined that meloxicam has a stronger anti-inflammatory effect by reducing the synthesis of tumor necrosis factor (TNF)-alpha, a cytokine with proinflammatory effects, as well as inhibiting the cyclooxygenase (COX)-2 enzyme in respiratory infections [21,22]. This evidence concerns the gene TNF and respiratory tract infectious disorder.